Deep-tech fundraising: what really matters
On Thursday, June 26th, our CEO, Kris Blanchard, PhD, will join fellow founders in a Meaningful Business session to share real-world fundraising insights from the frontlines of deep tech. He’ll speak about what it really takes to raise capital in biotechnology.
Fundraising in biotech isn’t just about pitch decks and projections. It’s about showing your technology can scale, proving you understand your regulatory and commercial roadmap, and building a team capable of executing in sectors being reshaped by cellular agriculture.
At Luyef, we’ve learned that investors in deep tech are looking for:
→ Rigorous scientific validation
→ A clear and realistic go-to-market strategy across verticals
→ A team fluent in both science and business execution
From food to biomedicine to cosmetics, cellular agriculture is transforming how we produce. This session is a rare opportunity to hear what happens behind the scenes when raising capital in high-impact, science-driven startups.
If you’re currently fundraising—or planning to—this is one you don’t want to miss.
📅 Thursday, June 26th, 1–2 PM GMT
🔗 Apply for Meaningful Business membership to join: https://lnkd.in/ebZnYfUy
